NCT06339203 Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
| NCT ID | NCT06339203 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Loma Linda University |
| Condition | Cesarean Section Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-06-05 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2024-06-05 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in 99.95% sterile water for irrigation. The study aims to evaluate the impact on postoperative wound healing in patients who have undergone cesarean delivery.
Eligibility Criteria
Inclusion Criteria: * Age 18 or older * Singleton pregnancy * Planned cesarean delivery at gestational age 37 weeks or later at Loma Linda University Children's Hospital * Planned post-operative follow up with Loma Linda OBGYN * Speak English or Spanish * At least one of the following medical complications: Obesity BMI\>= 30kg/m2, Diabetes, Spontaneous rupture of membranes, Intraamniotic infection Exclusion Criteria: * Emergency cesarean delivery
Contact & Investigator
Ruofan Yao, MD, MPH
PRINCIPAL INVESTIGATOR
Loma Linda University
Frequently Asked Questions
Who can join the NCT06339203 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cesarean Section Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06339203 currently recruiting?
Yes, NCT06339203 is actively recruiting participants. Contact the research team at nhutto@llu.edu for enrollment information.
Where is the NCT06339203 trial being conducted?
This trial is being conducted at Loma Linda, United States.
Who is sponsoring the NCT06339203 clinical trial?
NCT06339203 is sponsored by Loma Linda University. The principal investigator is Ruofan Yao, MD, MPH at Loma Linda University. The trial plans to enroll 400 participants.